| Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing K Doig | 274* | |
| Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer EL Christie, S Fereday, K Doig, S Pattnaik, SJ Dawson, DDL Bowtell Journal of Clinical Oncology 35 (12), 1274-1280, 2017 | 200 | 2017 |
| On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer KD Doig, KE Holt, JAM Fyfe, CJ Lavender, M Eddyani, F Portaels, ... BMC genomics 13, 1-19, 2012 | 175 | 2012 |
| Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary RW Tothill, J Li, L Mileshkin, K Doig, T Siganakis, P Cowin, A Fellowes, ... The Journal of pathology 231 (4), 413-423, 2013 | 120 | 2013 |
| Circulating tumor DNA analysis and functional imaging provide complementary approaches for comprehensive disease monitoring in metastatic melanoma SQ Wong, JM Raleigh, J Callahan, IA Vergara, S Ftouni, A Hatzimihalis, ... Precision Oncology 1, 1-14, 2017 | 115 | 2017 |
| Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia P Yeh, T Hunter, D Sinha, S Ftouni, E Wallach, D Jiang, YC Chan, ... Nature communications 8 (1), 14756, 2017 | 91 | 2017 |
| Decreased Vancomycin Susceptibility in Staphylococcus aureus Caused by IS256 Tempering of WalKR Expression CRE McEvoy, B Tsuji, W Gao, T Seemann, JL Porter, K Doig, D Ngo, ... Antimicrobial agents and chemotherapy 57 (7), 3240-3249, 2013 | 73 | 2013 |
| Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes P Yeh, M Dickinson, S Ftouni, T Hunter, D Sinha, SQ Wong, R Agarwal, ... Blood, The Journal of the American Society of Hematology 129 (12), 1685-1690, 2017 | 64 | 2017 |
| Complete genome sequence of the frog pathogen Mycobacterium ulcerans ecovar Liflandii NJ Tobias, KD Doig, MH Medema, H Chen, V Haring, R Moore, ... Journal of bacteriology 195 (3), 556-564, 2013 | 59 | 2013 |
| Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients SQ Wong, A Fellowes, K Doig, J Ellul, TJ Bosma, D Irwin, R Vedururu, ... British journal of cancer 112 (8), 1411-1420, 2015 | 51 | 2015 |
| Homologous recombination repair deficiency: an overview for pathologists KD Doig, AP Fellowes, SB Fox Modern Pathology 36 (3), 100049, 2023 | 36 | 2023 |
| PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories KD Doig, A Fellowes, AH Bell, A Seleznev, D Ma, J Ellul, J Li, MA Doyle, ... Genome medicine 9, 1-16, 2017 | 34 | 2017 |
| ASXL1 c.1934dup;p.Gly646Trpfs*12—a true somatic alteration requiring a new approach CK Yannakou, K Jones, M McBean, ER Thompson, GL Ryland, K Doig, ... Blood cancer journal 7 (12), 656, 2017 | 23 | 2017 |
| Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted … R Agarwal, P Blombery, M McBean, K Jones, A Fellowes, K Doig, ... Annals of hematology 96, 725-732, 2017 | 23 | 2017 |
| Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment J Li, MA Doyle, I Saeed, SQ Wong, V Mar, DL Goode, F Caramia, K Doig, ... PloS one 9 (4), e95217, 2014 | 20 | 2014 |
| ASXL1 c. 1934dup; p CK Yannakou, K Jones, M McBean, ER Thompson, GL Ryland, K Doig, ... Gly646Trpfs 12, 656, 2017 | 19 | 2017 |
| Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic Laboratory P Blombery, K Jones, K Doig, G Ryland, M McBean, E Thompson, ... Archives of pathology & laboratory medicine 142 (5), 606-612, 2018 | 13 | 2018 |
| Studying cancer genomics through next-generation DNA sequencing and bioinformatics MA Doyle, J Li, K Doig, A Fellowes, SQ Wong Clinical Bioinformatics, 83-98, 2014 | 13 | 2014 |
| Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation E Tudini, J Andrews, DM Lawrence, SL King-Smith, N Baker, L Baxter, ... The American Journal of Human Genetics 109 (11), 1960-1973, 2022 | 12 | 2022 |
| Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma. JCO Precis Oncol. 2017; 1: 1–14 SQ Wong, JM Raleigh, J Callahan, IA Vergara, S Ftouni, A Hatzimihalis, ... Study demonstrating concordance of ctDNA levels and metabolic tumour burden …, 2019 | 12 | 2019 |
